tiprankstipranks
Trending News
More News >
Enveric Biosciences (ENVB)
NASDAQ:ENVB
Advertisement

Enveric Biosciences (ENVB) Price & Analysis

Compare
532 Followers

ENVB Stock Chart & Stats


Enveric Biosciences News

ENVB FAQ

What was Enveric Biosciences’s price range in the past 12 months?
Enveric Biosciences lowest stock price was $0.56 and its highest was $8.33 in the past 12 months.
    What is Enveric Biosciences’s market cap?
    Enveric Biosciences’s market cap is $4.12M.
      When is Enveric Biosciences’s upcoming earnings report date?
      Enveric Biosciences’s upcoming earnings report date is Nov 12, 2025 which is in 41 days.
        How were Enveric Biosciences’s earnings last quarter?
        Enveric Biosciences released its earnings results on Aug 14, 2025. The company reported -$0.97 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.97.
          Is Enveric Biosciences overvalued?
          According to Wall Street analysts Enveric Biosciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Enveric Biosciences pay dividends?
            Enveric Biosciences does not currently pay dividends.
            What is Enveric Biosciences’s EPS estimate?
            Enveric Biosciences’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Enveric Biosciences have?
            Enveric Biosciences has 6,219,568 shares outstanding.
              What happened to Enveric Biosciences’s price movement after its last earnings report?
              Enveric Biosciences reported an EPS of -$0.97 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Enveric Biosciences?
                Currently, no hedge funds are holding shares in ENVB

                Company Description

                Enveric Biosciences

                Enveric Biosciences (ENVB) is a biotechnology company focused on developing innovative treatments for mental health disorders. The company leverages its expertise in neuroscience and psychedelic-inspired molecules to create novel therapeutic solutions aimed at addressing the unmet needs in mental health care. Enveric's pipeline is primarily concentrated on the research and development of treatments for conditions such as anxiety, depression, and post-traumatic stress disorder (PTSD).

                Enveric Biosciences (ENVB) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Aptevo Therapeutics
                Ensysce Biosciences
                CNS Pharmaceuticals
                Revelation Biosciences
                Tao Synergies

                Ownership Overview

                14.19%0.93%3.83%74.74%
                14.19% Insiders
                3.83% Other Institutional Investors
                74.74% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis